USING PAIN TOLERABILITY THRESHOLDS TO CHARACTERIZE CLINICALLY MEANINGFUL TREATMENT OUTCOMES IN KNEE OSTEOARTHRITIS: POST HOC ANALYSIS OF A PHASE 2B TRIAL OF INTRA-ARTICULAR LORECIV... von Markman, J.D., Bennett, H., Kennedy, S., Tambiah, J.R., Swearingen, C.J., Gewandter, J.S.

Volltext

Patient characteristics and factors affecting total knee replacement decision-making by different physician types treating knee osteoarthritis patients von Bedenbaugh, A.V., Oderda, G., Lee, V.C., Moller, J., Brixner, D., Kennedy, S., McAlindon, T., Tambiah, J.R.

Volltext

The patient journey in knee osteoarthritis-variations in diagnosis, patient characteristics, and treatment by physician specialty von Bedenbaugh, A.V., Oderda, G., Lee, V.C., Moller, J., Brixner, D., Kennedy, S., McAlindon, T., Tambiah, J.R.

Volltext

Radiographic outcomes were concordant with outcome measures in rheumatology-osteoarthritis research society international (OMERACT-OARSI) strict response: post-hoc analysis from a... von Yazici, Y., McAlindon, T.E., Gibofsky, A., Lane, N.E., Swearingen, C.J., Tambiah, J.R.

Volltext

Efficacy and safety from a phase 2B trial of SM04690, a novel, intra-articular, WNT pathway inhibitor for the treatment of osteoarthritis of the knee von Yazici, Y., McAlindon, T.E., Gibofsky, A., Lane, N.E., Latterman, C., Skrepnik, N., Swearingen, C.J., DiFrancesco, A., Tambiah, J.R., Hochberg, M.C.

Volltext

Results from a 52-week randomized, double-blind, placebo-controlled, phase 2 study of a novel, intra-articular wnt pathway inhibitor (SM04690) for the treatment of knee osteoarthri... von Yazici, Y., McAlindon, T.E., Gibofsky, A., Lane, N.E., Clauw, D.J., Jones, M.H., Bergfeld, J., Swearingen, C.J., DiFrancesco, A., Tambiah, J.R., Hochberg, M.

Volltext